CareDx Sets Price Range for Proposed IPO, Anticipates Net Proceeds of up to $50.5M | GenomeWeb

NEW YORK (GenomeWeb) – CareDx expects to price the shares in its proposed initial public offering at between $15 and $17 per share, with net proceeds anticipated at up to $50.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.